Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment

研究成果: Article

2 引文 (Scopus)
原文English
期刊Journal of Clinical Oncology
31
發行號1
DOIs
出版狀態Published - 2013 一月 1

指紋

Stomach Rupture
Quinazolines
Remission Induction
X Ray Computed Tomography
Antineoplastic Agents
Lung Neoplasms
Stomach
Adenocarcinoma
Adenocarcinoma of lung
gefitinib

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

引用此文

@article{39dc7dee83d14642adfacb47357716d9,
title = "Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment",
author = "Wei-Pang Chung and Song, {Hsiang Lin} and Chung-Liang Ho and Nan-Tsing Chiu and Wu-Chou Su",
year = "2013",
month = "1",
day = "1",
doi = "10.1200/JCO.2012.43.5578",
language = "English",
volume = "31",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "1",

}

TY - JOUR

T1 - Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment

AU - Chung, Wei-Pang

AU - Song, Hsiang Lin

AU - Ho, Chung-Liang

AU - Chiu, Nan-Tsing

AU - Su, Wu-Chou

PY - 2013/1/1

Y1 - 2013/1/1

UR - http://www.scopus.com/inward/record.url?scp=84871765740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871765740&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.43.5578

DO - 10.1200/JCO.2012.43.5578

M3 - Article

C2 - 23169516

AN - SCOPUS:84871765740

VL - 31

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 1

ER -